Nyxoah SA to Announce Q4 Financial Results and Insights

Nyxoah Set to Release Fourth Quarter and Year-End Financial Results

Nyxoah SA (NASDAQ: NYXH), a medical technology company dedicated to innovating treatment options for Obstructive Sleep Apnea (OSA), is gearing up to release its financial results for the fourth quarter and the complete financial year 2024. Scheduled for March 13, 2025, this announcement marks an important occasion for stakeholders eager to learn about the company's performance and future directions.

Details of the Earnings Release

The company's management team will be hosting a comprehensive conference call that day at 1:00 PM CET / 8:00 AM ET. During this session, they will discuss the financial results and share valuable insights into the company’s strategic initiatives moving forward. This event is especially significant as it showcases the company’s efforts and advancements in combating OSA.

Investors Can Access Webcast and Q&A

For those interested in tuning in, a webcast will be available via Nyxoah’s Investor Relations page. The company encourages participants who wish to pose questions to sign up through the provided link. An email will be sent to them shortly thereafter, including dial-in details and a unique access code necessary for joining the call. It’s recommended that those planning to participate register at least 10 minutes in advance to ensure a smooth connection.

About Nyxoah's Innovative Solutions

Nyxoah has made significant strides in the medical technology sector by developing groundbreaking treatment alternatives for OSA. Their flagship product, Genio®, is a battery-free hypoglossal neuromodulation device that is designed for ease of use by being inserted through a single incision under the chin. This innovative device stands out for its user-friendliness, being controlled with a wearable device, changing the way patients experience treatment.

Company Milestones and Growth

Nyxoah has achieved notable milestones throughout its journey. In 2019, after the successful completion of the BLAST OSA study, the Genio® system received the CE mark in Europe, paving the way for its clinical use. The company carried out two successful Initial Public Offerings - first on Euronext Brussels in September 2020 and then on NASDAQ in July 2021. The Genio® system also received expanded therapeutic indication approvals, enhancing treatment options for patients experiencing Complete Concentric Collapse, a condition that other therapies are unable to address.

Future Directions and Clinical Outcomes

Following positive results from the BETTER SLEEP study, Nyxoah announced its plans to apply for further regulatory approvals. Positive outcomes from pivotal studies have paved the way for potential commercialization in the U.S., emphasizing the company’s commitment to expanding its reach and capabilities in fight against OSA. Nyxoah aims to enhance the quality of life for the millions affected by sleep apnea globally through clinical innovations.

Frequently Asked Questions

When will Nyxoah release its fourth quarter financial results?

Nyxoah will release its fourth quarter financial results on March 13, 2025.

How can I participate in Nyxoah's conference call?

You can participate by registering for the conference call via the Investor Relations page on Nyxoah's website.

What innovative products does Nyxoah offer?

Nyxoah offers the Genio®, a hypoglossal neuromodulation device designed specifically for patients suffering from obstructive sleep apnea.

What are Nyxoah's recent achievements?

Nyxoah received its European CE Mark in 2019 and successfully completed IPOs on Euronext and NASDAQ, showcasing its growth in the medical technology sector.

What are the future plans for Nyxoah?

Nyxoah plans to pursue additional regulatory approvals in the U.S. to expand the commercialization of its innovative therapies.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.